Previous Page  12 / 28 Next Page
Information
Show Menu
Previous Page 12 / 28 Next Page
Page Background

CHAPTER 6 — The First Script

83

“You know, he’s the first damn doctor who ever listened to me.” Here we

have a nice example of a set of behaviorally defined interviewing

techniques

that have been woven together into an effective interviewing

strategy

for

enhancing the medication alliance while increasing medication interest.

For the Mini-Dose Recommendation to work effectively, several things

are worth noting. It seems to be important to “ask permission” at the end

of the technique, as reflected by my words, “What do you think?” because

such a question further reenforces our desire to work as a collaborative

team. Telling patients why we are recommending a low dose (as a response

to their concerns about being overly sensitive) is also important because it

conveys that we are not only carefully listening to the patient’s input but

also demonstrates that we are willing to act on it, a point not missed by

the patient.

In the above approach, we have seen our first example of a sequential

interviewing

strategy

. As you will recall from Chapter 2, interviewing strat-

egies occur when two or more specific interviewing

techniques

are serially

connected to achieve a set clinical goal. More specifically, if two or more

interviewing techniques can be used sequentially to achieve a specific

therapeutic goal more effectively, their order can be operationalized and the

sequence is given a name for ease of teaching and employment in clinical

practice (in this case, the pairing of the two interviewing techniques – the

Medication Sensitivity Inquiry and the Mini-Dose Recommendation – is

simply called the

Medication “Wary” Engagement Strategy

). I believe

that you may find the Medication “Wary” Engagement Strategy to be one of

your most effective strategies during an initial appointment for improving

medication interest and follow-through with your first new prescription.

I vividly remember a woman who had been suffering with a major

depressive episode for years, who had discontinued five consecutive

antidepressants “because I have had horrible side effects on those damn

things.” She had also been in ongoing psychotherapy with little relief. After

having applied the first technique (the Medication Sensitivity Inquiry) of

the Medication “Wary” Engagement Strategy, I employed the second tech-

nique, the Mini-Dose Recommendation (in this instance, at one-fourth the

typical starting dose). We gradually increased the dose over several months

at tiny amounts, and at her own pace, till we arrived at a therapeutic dos-

ing. Her depression went into a complete remission. Note that, even with

patients viewing themselves as overly sensitive to medications, with some

serious conditions it may be advantageous to start a medication at a typical

or higher-than-typical dose (Effective MIM approaches for such relatively

infrequent situations will be addressed later in the book).